BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

698 related articles for article (PubMed ID: 32124106)

  • 1. Carbapenem-resistant Enterobacteriaceae in patients with bacteraemia at tertiary hospitals in South Africa, 2015 to 2018.
    Perovic O; Ismail H; Quan V; Bamford C; Nana T; Chibabhai V; Bhola P; Ramjathan P; Swe Swe-Han K; Wadula J; Whitelaw A; Smith M; Mbelle N; Singh-Moodley A;
    Eur J Clin Microbiol Infect Dis; 2020 Jul; 39(7):1287-1294. PubMed ID: 32124106
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phenotypic and genotypic characteristics of carbapenem-resistant Enterobacteriaceae in a tertiary-level reference hospital in Turkey.
    Baran I; Aksu N
    Ann Clin Microbiol Antimicrob; 2016 Apr; 15():20. PubMed ID: 27048322
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Molecular characterization of carbapenem-resistant
    Yan WJ; Jing N; Wang SM; Xu JH; Yuan YH; Zhang Q; Li AL; Chen LH; Zhang JF; Ma B; Ma Q; Li Y
    J Med Microbiol; 2021 Mar; 70(3):. PubMed ID: 33587030
    [No Abstract]   [Full Text] [Related]  

  • 4. Molecular characterization of intestinal carriage of carbapenem-resistant Enterobacteriaceae among inpatients at two Iranian university hospitals: first report of co-production of bla
    Solgi H; Badmasti F; Aminzadeh Z; Giske CG; Pourahmad M; Vaziri F; Havaei SA; Shahcheraghi F
    Eur J Clin Microbiol Infect Dis; 2017 Nov; 36(11):2127-2135. PubMed ID: 28639165
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factors associated to prevalence and treatment of carbapenem-resistant Enterobacteriaceae infections: a seven years retrospective study in three tertiary care hospitals.
    Pang F; Jia XQ; Zhao QG; Zhang Y
    Ann Clin Microbiol Antimicrob; 2018 Mar; 17(1):13. PubMed ID: 29571291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In vitro activity of meropenem/vaborbactam and characterisation of carbapenem resistance mechanisms among carbapenem-resistant Enterobacteriaceae from the 2015 meropenem/vaborbactam surveillance programme.
    Pfaller MA; Huband MD; Mendes RE; Flamm RK; Castanheira M
    Int J Antimicrob Agents; 2018 Aug; 52(2):144-150. PubMed ID: 29510189
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology of Carbapenem-Resistant Enterobacteriaceae Infections: Report from the China CRE Network.
    Zhang Y; Wang Q; Yin Y; Chen H; Jin L; Gu B; Xie L; Yang C; Ma X; Li H; Li W; Zhang X; Liao K; Man S; Wang S; Wen H; Li B; Guo Z; Tian J; Pei F; Liu L; Zhang L; Zou C; Hu T; Cai J; Yang H; Huang J; Jia X; Huang W; Cao B; Wang H
    Antimicrob Agents Chemother; 2018 Feb; 62(2):. PubMed ID: 29203488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical and Molecular Epidemiology of Carbapenem-Resistant Enterobacteriaceae Among Adult Inpatients in Singapore.
    Marimuthu K; Venkatachalam I; Khong WX; Koh TH; Cherng BPZ; Van La M; De PP; Krishnan PU; Tan TY; Choon RFK; Pada SK; Lam CW; Ooi ST; Deepak RN; Smitasin N; Tan EL; Lee JJ; Kurup A; Young B; Sim NTW; Thoon KC; Fisher D; Ling ML; Peng BAS; Teo YY; Hsu LY; Lin RTP; Ong RT; Teo J; Ng OT;
    Clin Infect Dis; 2017 May; 64(suppl_2):S68-S75. PubMed ID: 28475792
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Carbapenem-resistant Enterobacterales in patients with bacteraemia at tertiary academic hospitals in South Africa, 2019 - 2020: An update.
    Lowe M; Shuping L; Perovic O
    S Afr Med J; 2022 Aug; 112(8):542-552. PubMed ID: 36214398
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Successful containment of carbapenem-resistant Enterobacteriaceae by strict contact precautions without active surveillance.
    Kim NH; Han WD; Song KH; Seo HK; Shin MJ; Kim TS; Park KU; Ahn S; Yoo JS; Kim ES; Kim HB
    Am J Infect Control; 2014 Dec; 42(12):1270-3. PubMed ID: 25465255
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phenotypic and Genotypic Characterization of Carbapenem-resistant Enterobacteriaceae: Data From a Longitudinal Large-scale CRE Study in China (2012-2016).
    Wang Q; Wang X; Wang J; Ouyang P; Jin C; Wang R; Zhang Y; Jin L; Chen H; Wang Z; Zhang F; Cao B; Xie L; Liao K; Gu B; Yang C; Liu Z; Ma X; Jin L; Zhang X; Man S; Li W; Pei F; Xu X; Jin Y; Ji P; Wang H
    Clin Infect Dis; 2018 Nov; 67(suppl_2):S196-S205. PubMed ID: 30423057
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparing the Outcomes of Patients With Carbapenemase-Producing and Non-Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae Bacteremia.
    Tamma PD; Goodman KE; Harris AD; Tekle T; Roberts A; Taiwo A; Simner PJ
    Clin Infect Dis; 2017 Feb; 64(3):257-264. PubMed ID: 28013264
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Meropenem-Vaborbactam Activity against Carbapenem-Resistant
    Castanheira M; Doyle TB; Kantro V; Mendes RE; Shortridge D
    Antimicrob Agents Chemother; 2020 Jan; 64(2):. PubMed ID: 31712207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Carbapenem-Resistant Enterobacteriaceae Detection Practices in California: What Are We Missing?
    Humphries RM; Hindler JA; Epson E; Horwich-Scholefield S; Miller LG; Mendez J; Martinez JB; Sinkowitz J; Sinkowtiz D; Hershey C; Marquez P; Bhaurla S; Moran M; Pandes L; Terashita D; McKinnell JA
    Clin Infect Dis; 2018 Mar; 66(7):1061-1067. PubMed ID: 29099915
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic characterization of an emerging bla
    Kerdsin A; Deekae S; Chayangsu S; Hatrongjit R; Chopjitt P; Takeuchi D; Akeda Y; Tomono K; Hamada S
    Sci Rep; 2019 Dec; 9(1):18521. PubMed ID: 31811215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rapid Increase in Prevalence of Carbapenem-Resistant Enterobacteriaceae (CRE) and Emergence of Colistin Resistance Gene
    Li Y; Sun QL; Shen Y; Zhang Y; Yang JW; Shu LB; Zhou HW; Wang Y; Wang B; Zhang R; Wang S; Shen Z
    J Clin Microbiol; 2018 Apr; 56(4):. PubMed ID: 29386265
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Phenotypic and molecular characteristics of carbapenem-resistant Enterobacteriaceae in a health care system in Los Angeles, California, from 2011 to 2013.
    Pollett S; Miller S; Hindler J; Uslan D; Carvalho M; Humphries RM
    J Clin Microbiol; 2014 Nov; 52(11):4003-9. PubMed ID: 25210072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk factors and outcomes associated with the isolation of polymyxin B and carbapenem-resistant Enterobacteriaceae spp.: A case-control study.
    Teo JQ; Chang CW; Leck H; Tang CY; Lee SJ; Cai Y; Ong RT; Koh TH; Tan TT; Kwa AL
    Int J Antimicrob Agents; 2019 May; 53(5):657-662. PubMed ID: 30880229
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Carbapenemase-Producing Enterobacteriaceae and Nonfermentative Bacteria, the Philippines, 2013-2016.
    Velasco JM; Valderama MT; Peacock T; Warawadee N; Nogrado K; Navarro FC; Chua D; Apichai S; Sirigade R; Macareo LR; Swierczewski B
    Emerg Infect Dis; 2017 Sep; 23(9):1597-1598. PubMed ID: 28820383
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk Factors and Molecular Epidemiology of Complicated Intra-Abdominal Infections With Carbapenem-Resistant Enterobacteriaceae: A Multicenter Study in China.
    Liu J; Zhang L; Pan J; Huang M; Li Y; Zhang H; Wang R; Zhao M; Li B; Liu L; Gong Y; Bian J; Li X; Tang Y; Lei M; Chen D
    J Infect Dis; 2020 Mar; 221(Suppl 2):S156-S163. PubMed ID: 32176797
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.